Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

MSS duodenal adenocarcinoma achieves durable response with nivolumab and cetuximab

A man with refractory MSS duodenal adenocarcinoma achieved a durable complete response after nivolumab, ipilimumab, and cetuximab.

UK study uses validated financial toxicity scoring to examine cancer patients and survivors across recruitment pathways, with cross-sectional…

BMJ Open protocol outlines a scoping review of immune checkpoint inhibitors added to definitive radiotherapy for locally advanced…

BioMedRTC in Sofia is recruiting an established research leader to build a cancer or rare disease group with…

Prospective lung resection study links lung microbiome patterns with malignancy site, TP53 and KRAS mutations, and prolonged air…

SCP-7e selectively binds CDK4, drives its degradation, and shows stronger anti-NSCLC activity than SCP-7 in preclinical models.

A review of prostate cancer nanomaterials details PSMA-targeted imaging, drug delivery, and translational barriers slowing clinical adoption.

A 2026 review examines NIR-II fluorescence laparoscopy, from prostate and bladder targeting to nanotoxicology and surgical integration barriers.

Johnson & Johnson’s Rybrevant Faspro won accelerated FDA approval for advanced head and neck squamous cell carcinoma after…

Savana Next-Generation Registry uses NLP to convert unstructured oncology EHR text into analysis-ready real-world evidence under European data…

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds